Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome Medical Dialogues Bureau24 Jan 2020 11:31 AM ISTHod Hasharon: Wize Pharma a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has...
Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™ for Dry Eye Disease Medical Dialogues Bureau19 Jan 2020 10:45 AM ISTWatertown: Kala Pharmaceuticals, Inc. (Kala), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...
FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US Farhat Nasim14 Oct 2019 1:13 PM ISTNew Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...